ResMed Inc. Deferred Foreign Income Tax Expense (Benefit)
ResMed Inc. (RSMDF) reported Deferred Foreign Income Tax Expense (Benefit) of -$39.17 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-13.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredForeignIncomeTaxExpenseBenefit · last filed 2026-08-13
- ResMed Inc. deferred foreign income tax expense (benefit) for fiscal 2026 was -$39.17M.
- ResMed Inc. deferred foreign income tax expense (benefit) for fiscal 2025 was -$54.06M.
- ResMed Inc. deferred foreign income tax expense (benefit) for fiscal 2024 was -$22.33M.
- ResMed Inc. deferred foreign income tax expense (benefit) for fiscal 2023 was -$21.32M, a 697.76% decline from fiscal 2022.
| Period end | Deferred Foreign Income Tax Expense (Benefit) 12 month |
|---|---|
| 2026-06-30 | -$39.17M 10-K · filed 2026-08-13 |
| 2025-06-30 | -$54.06M 10-K · filed 2026-08-13 |
| 2024-06-30 | -$22.33M 10-K · filed 2026-08-13 |
| 2023-06-30 | -$21.32M 10-K · filed 2025-08-08 |
| 2022-06-30 | $3.57M 10-K · filed 2024-08-09 |
| 2021-06-30 | $10.41M 10-K · filed 2023-08-11 |
| 2020-06-30 | -$13.54M 10-K · filed 2022-08-12 |
| 2019-06-30 | -$13.67M 10-K · filed 2021-08-17 |
| 2018-06-30 | -$2.19M 10-K · filed 2020-08-13 |
| 2017-06-30 | -$18.55M 10-K · filed 2019-08-08 |
| 2016-06-30 | -$4.99M 10-K · filed 2018-08-17 |
| 2015-06-30 | $7.46M 10-K · filed 2017-08-04 |
| 2014-06-30 | $10.37M 10-K · filed 2016-08-05 |
| 2013-06-30 | -$17.07M 10-K · filed 2015-08-07 |
| 2012-06-30 | -$12.09M 10-K · filed 2014-08-08 |
| 2011-06-30 | $3.37M 10-K · filed 2013-08-13 |
| 2010-06-30 | $1.45M 10-K · filed 2012-08-14 |
| 2009-06-30 | -$15.62M 10-K · filed 2011-08-17 |